Kirsty Morrison

Two-Year Outcomes of the SPARC Phase II Trial: Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Prostate Cancer

Binnaz Yasar, Yae-Eun Suh, Ewan Chapman, Luke Nicholls et autres

gb, au (code pays fourni par la source)

2956 Clinical Evaluation of 2D and 3D Deep Learning-based CT Auto-contouring in Prostate Cancer.

Maram Alqarni, C. Thomas, Vinod Mullassery, Simon Hughes et autres

Implementation of in-house pelvic radiotherapy auto-contouring in real-world clinical practice

Luı́s Ribeiro, Christopher Thomas, Maram Alqarni, Anil Mistry et autres

gb, au (code pays fourni par la source)

491: SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial

Binnaz Yasar, Yae‐Eun Suh, Ewan Chapman, Luke Nicholls et autres

Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 Trial

Binnaz Yasar, Yae‐Eun Suh, Ewan Chapman, Luke Nicholls et autres

gb, au (code pays fourni par la source)

The dermatologist identity crisis: a phenomenological analysis of dermatology trainee professional identity during generalist redeployment

Jonathan Guckian, Natasha Lee, Jonathan E. Sutton, Nabilah Y. Mayat et autres

gb (code pays fourni par la source)

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Alison Tree, Peter Ostler, H. van der Voet, William Chu et autres

gb, ca, ie, us (code pays fourni par la source)

Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial

Luke Nicholls, Yae‐Eun Suh, Ewan Chapman, Daniel Henderson et autres

gb, au (code pays fourni par la source)

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas Brand, Alison Tree, Peter Ostler, H. van der Voet et autres

gb, ca (code pays fourni par la source)

PACE: Analysis of acute toxicity in PACE-B, an international phase III randomized controlled trial comparing stereotactic body radiotherapy (SBRT) to conventionally fractionated or moderately hypofractionated external beam radiotherapy (CFMHRT) for localized prostate cancer (LPCa).

Nicholas John Van As, Douglas Brand, Alison Tree, Peter Ostler et autres

gb, ca, us (code pays fourni par la source)

Summary of Ongoing Prospective Trials Using SBRT for Prostate Cancer

Kirsty Morrison, Nicholas van As

gb (code pays fourni par la source)

The PACE trial: International randomised study of laparoscopic prostatectomy vs. stereotactic body radiotherapy (SBRT) and standard radiotherapy vs. SBRT for early stage organ-confined prostate cancer.

Kirsty Morrison, Alison Tree, Vincent Khoo, Nicholas John Van As

gb (code pays fourni par la source)